Literature DB >> 34117084

Vaccines and Disease Relapses in Children with Nephrotic Syndrome.

Andrea Angeletti1, Maurizio Bruschi2, Silvia Bianchin1, Irene Bonato1, Carolina Montobbio1, Enrico Verrina1, Francesca Lugani2, Paolo Cravedi3, Gian Marco Ghiggeri4.   

Abstract

Entities:  

Keywords:  COVID-19; children; idiopathic nephrotic syndrome; nephrotic syndrome; pediatric nephrology; rituximab; steroid dependent nephrotic syndrome; vaccines

Mesh：

Substances：

Year:  2021        PMID： 34117084      PMCID： PMC8216624          DOI： 10.2215/CJN.01890221

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   10.614


× No keyword cloud information.
  4 in total

1.  Relapse of nephrotic syndrome following the use of 2009 pandemic influenza A (H1N1) vaccine.

Authors:  Paulo Fernandes; Sofia Jorge; José António Lopes
Journal:  Am J Kidney Dis       Date:  2010-07       Impact factor: 8.860

2.  Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial.

Authors:  Pietro Ravani; Roberta Rossi; Alice Bonanni; Robert R Quinn; Felice Sica; Monica Bodria; Andrea Pasini; Giovanni Montini; Alberto Edefonti; Mirco Belingheri; Donatella De Giovanni; Giancarlo Barbano; Ludovica Degl'Innocenti; Francesco Scolari; Luisa Murer; Jochen Reiser; Alessia Fornoni; Gian Marco Ghiggeri
Journal:  J Am Soc Nephrol       Date:  2015-01-15       Impact factor: 10.121

Review 3.  Safety and Efficacy of Pneumococcal Vaccination in Pediatric Nephrotic Syndrome.

Authors:  Shamitha Thishakya Goonewardene; Calyn Tang; Loh Teng-Hern Tan; Kok-Gan Chan; Prithvy Lingham; Learn-Han Lee; Bey-Hing Goh; Priyia Pusparajah
Journal:  Front Pediatr       Date:  2019-08-13       Impact factor: 3.418

4.  Influenza virus vaccination in children with nephrotic syndrome: insignificant risk of relapse.

Authors:  Shingo Ishimori; Koichi Kamei; Takashi Ando; Takahisa Yoshikawa; Yuji Kano; Hiroko Nagata; Ken Saida; Mai Sato; Masao Ogura; Shuichi Ito; Kenji Ishikura
Journal:  Clin Exp Nephrol       Date:  2020-07-27       Impact factor: 2.617
  4 in total
  5 in total

Review 1.  IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome.

Authors:  Agnes Trautmann; Olivia Boyer; Elisabeth Hodson; Arvind Bagga; Debbie S Gipson; Susan Samuel; Jack Wetzels; Khalid Alhasan; Sushmita Banerjee; Rajendra Bhimma; Melvin Bonilla-Felix; Francisco Cano; Martin Christian; Deirdre Hahn; Hee Gyung Kang; Koichi Nakanishi; Hesham Safouh; Howard Trachtman; Hong Xu; Wendy Cook; Marina Vivarelli; Dieter Haffner
Journal:  Pediatr Nephrol       Date:  2022-10-21       Impact factor: 3.651

2.  Idiopathic nephrotic syndrome relapse following COVID-19 vaccination: a series of 25 cases.

Authors:  Aurélie Hummel; Julie Oniszczuk; Delphine Kervella; Marina Charbit; Dominique Guerrot; Angelo Testa; Carole Philipponnet; Cécile Chauvet; Thomas Guincestre; Karine Brochard; Ariane Benezech; Lucile Figueres; Xavier Belenfant; Andrea Guarnieri; Nathalie Demoulin; Elisa Benetti; Marius Miglinas; Kathleen Dessaix; Johann Morelle; Andrea Angeletti; Anne-Laure Sellier-Leclerc; Bruno Ranchin; Guillaume Goussard; Laurent Hudier; Justine Bacchetta; Aude Servais; Vincent Audard
Journal:  Clin Kidney J       Date:  2022-05-06

Review 3.  Molecular Mechanisms of Proteinuria in Minimal Change Disease.

Authors:  Shrey Purohit; Federica Piani; Flor A Ordoñez; Carmen de Lucas-Collantes; Colin Bauer; Gabriel Cara-Fuentes
Journal:  Front Med (Lausanne)       Date:  2021-12-23

Review 4.  COVID-19 and idiopathic nephrotic syndrome in children: systematic review of the literature and recommendations from a highly affected area.

Authors:  William Morello; Federica Alessandra Vianello; Emanuele Proverbio; Licia Peruzzi; Andrea Pasini; Giovanni Montini
Journal:  Pediatr Nephrol       Date:  2021-10-23       Impact factor: 3.651

5.  Immunogenicity and safety of SARS-CoV-2 mRNA vaccine in patients with nephrotic syndrome receiving immunosuppressive agents.

Authors:  Koichi Kamei; Masao Ogura; Mai Sato; Kentaro Nishi; Kensuke Shoji; Takanori Funaki; Chikara Ogimi; Shuichi Ito
Journal:  Pediatr Nephrol       Date:  2022-08-01       Impact factor: 3.651
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.